Potential of nanoparticulate drug delivery systems by intranasal administration
- PMID: 20210751
- DOI: 10.2174/138161210791164108
Potential of nanoparticulate drug delivery systems by intranasal administration
Abstract
Due to number of problems related with oral, parenteral, rectal and other routes of drug administration, the interest of pharmaceutical scientists has increased towards exploring the possibilities of intranasal delivery of various drugs. Nasal drug delivery system is commonly known for the treatment of local ailments like cold, cough, rhinitis, etc. Efforts have been made to deliver various drugs, especially peptides and proteins, through nasal route for systemic use; utilizing the principles and concepts of various nanoparticulate drug delivery systems using various polymers and absorption promoters. The incorporation of drugs into nanoparticles might be a promising approach, since colloidal formulations have been shown to protect them from the degrading milieu in the nasal cavity and facilitate their transport across the mucosal barriers. The use of nanoparticles for vaccine delivery provides beneficial effect, by achieving good immune responses. This could be due to the fact that small particles can be transported preferentially by the lymphoid tissue of the nasal cavity (NALT). The brain gets benefited through the intranasal delivery as direct olfactory transport bypasses the blood brain barrier and nanoparticles are taken up and conveyed along cell processes of olfactory neurons through the cribriform plate to synaptic junctions with neurons of the olfactory bulb. The intranasal delivery is aimed at optimizing drug bioavailability for systemic drugs, as absorption decreases with increasing molecular weight, and for drugs, which are susceptible to enzymatic degradation such as proteins and polypeptides. This review discusses the potential benefits of using nanoparticles for nasal delivery of drugs and vaccines for brain, systemic and topical delivery. The article aims at giving an insight into nasal cavity, consideration of factors affecting and strategies to improve drug absorption through nasal route, pharmaceutical dosage forms and delivery systems with examples of some patents for intranasal delivery, its advantages and limitations.
Similar articles
-
Recent trends in drug delivery systems: intranasal drug delivery.Indian J Exp Biol. 1999 Jan;37(1):6-16. Indian J Exp Biol. 1999. PMID: 10355359 Review.
-
Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?J Pharm Sci. 2007 Mar;96(3):473-83. doi: 10.1002/jps.20718. J Pharm Sci. 2007. PMID: 17117404 Review.
-
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.Curr Med Chem. 2019;26(35):6459-6492. doi: 10.2174/0929867326666190827151741. Curr Med Chem. 2019. PMID: 31453778 Review.
-
Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.Mol Pharm. 2024 Mar 4;21(3):999-1014. doi: 10.1021/acs.molpharmaceut.3c00588. Epub 2024 Feb 8. Mol Pharm. 2024. PMID: 38329097 Review.
-
Nanoparticles for direct nose-to-brain delivery of drugs.Int J Pharm. 2009 Sep 8;379(1):146-57. doi: 10.1016/j.ijpharm.2009.06.019. Epub 2009 Jun 23. Int J Pharm. 2009. PMID: 19555750 Review.
Cited by
-
A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins.ScientificWorldJournal. 2013 Apr 18;2013:767482. doi: 10.1155/2013/767482. Print 2013. ScientificWorldJournal. 2013. PMID: 23710148 Free PMC article. Review.
-
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.Int J Nanomedicine. 2016 Dec 7;11:6547-6559. doi: 10.2147/IJN.S120939. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27994458 Free PMC article.
-
Designing DNA nanodevices for compatibility with the immune system of higher organisms.Nat Nanotechnol. 2015 Sep;10(9):741-7. doi: 10.1038/nnano.2015.180. Nat Nanotechnol. 2015. PMID: 26329110 Free PMC article.
-
Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit.Front Pharmacol. 2022 Jan 11;12:757761. doi: 10.3389/fphar.2021.757761. eCollection 2021. Front Pharmacol. 2022. PMID: 35087403 Free PMC article. Review.
-
New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery.Acta Pharm Sin B. 2022 Aug;12(8):3215-3232. doi: 10.1016/j.apsb.2022.04.001. Epub 2022 Apr 7. Acta Pharm Sin B. 2022. PMID: 35967290 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources